Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis
- 24 August 2023
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 202 (1) , 1-9
Abstract
Objective Breast cancer patients receiving neoadjuvant therapy (NAT) are in need of a more patient-friendly imaging modality such as contrast-enhanced mammography (CEM) for monitoring therapy response. The purpose of this study was to conduct a meta-analysis to compare the diagnostic performances of CEM and contrast-enhanced magnetic resonance imaging (CE-MRI) for assessing pathological complete response (pCR) in these patients. Methods The PubMed, Embase, and Cochrane Library databases were searched through March 2023 to identify studies reporting a head-to-head comparison of CEM and CE-MRI in detecting pCR in breast cancer patients receiving NAT. Pooled diagnostic performance was calculated using a bivariate random-effects model, and an AUC was derived for each test from hierarchic summary ROC analysis. Results Six studies with 328 patients were included. Pooled sensitivity, specificity, and diagnostic odds ratio (DOR) were 93% (95% CI 84–97%), 68% (95% CI 60–76%), and 29.29 (95% CI 11.41–75.18) for CEM versus 84% (95% CI 62–95%), 80% (95% CI 71–87%), and 21.39 (95% CI 5.94–77.13) for CE-MRI. The AUC was 0.85 (95% CI 0.82–0.88) for CEM and 0.85 (95% CI 0.82–0.88) for CE-MRI. Conclusion This meta-analysis of head-to-head comparison studies showed that CEM provides an equivalent diagnostic accuracy to CE-MRI in identification of pCR in breast cancer patients receiving NAT. The results support the increasing use of CEM in this setting and would encourage future studies to validate CEM as a suitable replacement for MRI.Keywords
This publication has 38 references indexed in Scilit:
- Contrast‐enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and toleranceJournal of Medical Imaging and Radiation Oncology, 2015
- Dual-energy contrast-enhanced spectral mammography (CESM)Archives of Gynecology and Obstetrics, 2015
- Role of Imaging in Neoadjuvant Therapy for Breast CancerAnnals of Surgical Oncology, 2015
- Interventions to reduce anxiety, distress and the need for sedation in adult patients undergoing magnetic resonance imaging: a systematic reviewJBI Evidence Implementation, 2013
- Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour sizeEuropean Radiology, 2013
- Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant TherapyJNCI: Journal of the National Cancer Institute, 2013
- Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRIThe Breast, 2012
- Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIALRadiology, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Anxiety-Related Reactions Associated With Magnetic Resonance Imaging ExaminationsJAMA, 1993